Authors

• Julia Kretz (ORCID: https://orcid.org/0000-0002-5408-4583)
• Vishal Goriya
• Citadel J. Cabasag (ORCID: https://orcid.org/0000-0003-0680-0060)
• Maximilian J. Hochmair (ORCID: https://orcid.org/0000-0002-8673-2450)
• Huamao Mark Lin (ORCID: https://orcid.org/0000-0002-8399-8966)
• Ji‐Youn Han (ORCID: https://orcid.org/0000-0001-5033-0006)
• Myung‐Ju Ahn (ORCID: https://orcid.org/0000-0002-5376-5109)
• Robert J. Fram (ORCID: https://orcid.org/0000-0001-7216-3130)
• Tsung‐Ying Yang (ORCID: https://orcid.org/0000-0003-0198-1077)
• Karin Holmskov Hansen (ORCID: https://orcid.org/0009-0000-7619-8779)
• Angelo Delmonte (ORCID: https://orcid.org/0000-0001-9065-6123)
• Yuzhe Zhao (ORCID: https://orcid.org/0000-0002-5852-6617)
• Bradley Hupf
• Yin Wan
• James C. Yang (ORCID: https://orcid.org/0000-0001-8935-5008)
• Yanyu Wu (ORCID: https://orcid.org/0000-0003-0773-5854)
• Eric N. Churchill
• Sharmistha Ghosh
• AS Kurec
• M.R. García Campelo

Institutions

• Universidade da Coruña (ES)
• Guy's and St Thomas' NHS Foundation Trust (GB)
• Odense University Hospital (DK)
• Samsung Medical Center (KR)
• IQVIA (United Kingdom) (GB)
• Takeda (Switzerland) (CH)
• Taichung Veterans General Hospital (TW)
• Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
• Takeda (Singapore) (SG)
• Thomas Foundation (AU)
• IQVIA (United States) (US)
• National Cancer Center (KR)
• National Taiwan University Hospital (TW)
• Takeda (United States) (US)
• IQ Solutions (US)
• Takeda (Japan) (JP)
• Sungkyunkwan University (KR)

Publication Details

Journal

Future Oncology

Published

2025-12-18

DOI

https://doi.org/10.1080/14796694.2025.2592527

Primary Topic

Lung Cancer Treatments and Mutations

Type

article

Field-Weighted Citation Impact

0.00